Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

<p>Abstract</p> <p>Background</p> <p>Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic syndrome as defined by the World H...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Scott Russell, Donoghoe Mark, Watts Gerald F, O'Brien Richard, Pardy Christopher, Taskinen Marja-Riitta, Davis Timothy ME, Colman Peter G, Manning Patrick, Fulcher Gregory, Keech Anthony C
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2011-11-01
Ráidu:	Cardiovascular Diabetology
Liŋkkat:	http://www.cardiab.com/content/10/1/102
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!